93
Views
35
CrossRef citations to date
0
Altmetric
CASE REPORT

Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis

, , , , &
Pages 577-581 | Received 20 Apr 2012, Accepted 30 May 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

N Kougkas, G Bertsias, R Stratoudaki & N Avgoustidis. (2021) Successful treatment of Cogan’s syndrome with tocilizumab. Scandinavian Journal of Rheumatology 50:4, pages 330-331.
Read now
Roberto Padoan, Diego Cazzador, Alfonso Luca Pendolino, Mara Felicetti, Susanna De Pascalis, Elisabetta Zanoletti, Roberto Bovo, Alessandro Martini & Franco Schiavon. (2019) Cogan’s syndrome: new therapeutic approaches in the biological era. Expert Opinion on Biological Therapy 19:8, pages 781-788.
Read now
Vittorio D’Aguanno, Massimo Ralli, Marco de Vincentiis & Antonio Greco. (2018) Optimal management of Cogan’s syndrome: a multidisciplinary approach. Journal of Multidisciplinary Healthcare 11, pages 1-11.
Read now

Articles from other publishers (32)

Misako Higashida-Konishi, Mitsuhiro Akiyama, Hiroki Tabata, Satoshi Hama, Tatsuhiro Oshige, Keisuke Izumi, Hisaji Oshima & Yutaka Okano. (2023) Atypical Cogan's Syndrome with Large-vessel Vasculitis Successfully Treated with Tocilizumab. Internal Medicine 62:22, pages 3413-3417.
Crossref
Kazusato Hara, Masataka Umeda, Keiko Segawa, Midori Akagi, Yushiro Endo, Tomohiro Koga, Shin-ya Kawashiri, Kunihiro Ichinose, Hideki Nakamura, Takahiro Maeda & Atsushi Kawakami. (2022) Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab. Internal Medicine 61:8, pages 1265-1270.
Crossref
Scott W. Gorthey, Shresh Pathak & Andrea Vambutas. (2021) The Correlation of Clinical Corticosteroid Responsiveness With Expression of IL-6 in Peripheral Blood Immune Cells (PBMC) in Patients With Autoimmune Inner Ear Disease (AIED). Otology & Neurotology 42:9, pages 1422-1428.
Crossref
Henry W. Zhou, Ann Q. Tran, Andrea A. Tooley, Jeremy T. MiyauchiMichael Kazim. (2021) Atypical Cogan Syndrome Featuring Orbital Myositis and Dacryoadenitis. Ophthalmic Plastic & Reconstructive Surgery 37:3S, pages S160-S162.
Crossref
A. Mekinian, J. Pouchot, T. Zenone & O. Fain. (2021) Syndrome de Cogan. La Revue de Médecine Interne 42:4, pages 269-274.
Crossref
Iván Cabezas-Rodríguez, Anahy Brandy-García, Carlos Rodríguez-Balsera, Paloma Rozas-Reyes, Belen Fernández-Llana & Luis Arboleya-Rodríguez. (2019) Late-onset Cogan's syndrome associated with large-vessel vasculitis. Reumatología Clínica (English Edition) 15:5, pages e30-e32.
Crossref
Iván Cabezas-Rodríguez, Anahy Brandy-García, Carlos Rodríguez-Balsera, Paloma Rozas-Reyes, Belen Fernández-Llana & Luis Arboleya-Rodríguez. (2019) Late-onset Cogan's syndrome associated with large-vessel vasculitis. Reumatología Clínica 15:5, pages e30-e32.
Crossref
Marina Mesquida, Victor Llorenç & Alfredo Adán. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis 95 112 .
Isabel de la Cámara Fernández, Rina Aicxa Molina Larios & Beatriz Joven Ibáñez. (2018) Cogan's syndrome: A case report with partial response to tocilizumab and a literature review. Revista Colombiana de Reumatología (English Edition) 25:4, pages 298-300.
Crossref
Isabel de la Cámara Fernández, Rina Aicxa Molina Larios & Beatriz Joven Ibáñez. (2018) Síndrome de Cogan: descripción de un caso con respuesta parcial a tocilizumab y revisión de la literatura. Revista Colombiana de Reumatología 25:4, pages 298-300.
Crossref
Jean-Marie Berthelot. (2018) Associations rares ou trompeuses entre pathologies articulaires et pathologies ORL. Revue du Rhumatisme Monographies 85:4, pages 308-313.
Crossref
Marina MesquidaBlanca MolinsVictor LlorençMaría V. Hernández, Gerard EspinosaMaite Sainz de la MazaAlfredo Adán. (2018) TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Retina 38:7, pages 1361-1370.
Crossref
Oded Shamriz, Yuval Tal & Menachem Gross. (2018) Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan’s Syndrome. Journal of Immunology Research 2018, pages 1-8.
Crossref
Charlotte Durtette, Eric Hachulla, Matthieu Resche-Rigon, Thomas Papo, Thierry Zénone, Bertrand Lioger, Christophe Deligny, Marc Lambert, Cédric Landron, Jacques Pouchot, Jean Emmanuel Kahn, Christian Lavigne, Benoit De Wazieres, Robin Dhote, Guillaume Gondran, Edouard Pertuiset, Thomas Quemeneur, Mohamed Hamidou, Pascal Sève, Thomas Le Gallou, Anne Grasland, Pierre-Yves Hatron, Olivier Fain & Arsène Mekinian. (2017) Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmunity Reviews 16:12, pages 1219-1223.
Crossref
Marina Mesquida, Blanca Molins, Víctor Llorenç, Maite Sáinz de la Maza & Alfredo Adán. (2017) Targeting interleukin-6 in autoimmune uveitis. Autoimmunity Reviews 16:10, pages 1079-1089.
Crossref
Giuseppe Lopalco, Claudia Fabiani, Jurgen Sota, Orso Maria Lucherini, Gian Marco Tosi, Bruno Frediani, Florenzo Iannone, Mauro Galeazzi, Rossella Franceschini, Donato Rigante & Luca Cantarini. (2017) IL-6 blockade in the management of non-infectious uveitis. Clinical Rheumatology 36:7, pages 1459-1469.
Crossref
Paolo Mora, Giacomo Calzetti, S. Ghirardini, P. Rubino, S. Gandolfi & J. Orsoni. (2017) Cogan's syndrome: State of the art of systemic immunosuppressive treatment in adult and pediatric patients. Autoimmunity Reviews 16:4, pages 385-390.
Crossref
Sumidha Mittal, Manjari Agarwal & Sujata Sawhney. 2017. Pediatric Rheumatology. Pediatric Rheumatology 525 534 .
Victoria Chang. 2017. Uveitis. Uveitis 149 163 .
Christoph Tappeiner, Marina Mesquida, Alfredo Adán, Jordi Anton, Athimalaipet V. Ramanan, Ester Carreno, Friederike Mackensen, Kaisu Kotaniemi, Joke H. de Boer, Rosa Bou, Carmen García de Vicuña & Arnd Heiligenhaus. (2016) Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. The Journal of Rheumatology 43:12, pages 2183-2188.
Crossref
Luca Cimino, Luigi Fontana & Carlo Salvarani. 2016. Intraocular Inflammation. Intraocular Inflammation 749 754 .
Rosanna Dammacco. 2016. Systemic Vasculitides: Current Status and Perspectives. Systemic Vasculitides: Current Status and Perspectives 289 297 .
Jared E. Knickelbein, Karen R. Armbrust, Meredith Kim, H. Nida Sen & Robert B. Nussenblatt. 2017. Pharmacologic Therapy of Ocular Disease. Pharmacologic Therapy of Ocular Disease 231 268 .
James P. Utz, Praveen K. Jinnur, Eunhee S. Yi, Jay H. Ryu, David E. Midthun & John M. DavisIIIIII. (2015) Acute Bilateral Pulmonary Opacities Associated With Use of Tocilizumab. JCR: Journal of Clinical Rheumatology 21:7, pages 382-385.
Crossref
Caroline B?al, Mehdi Yahia, Farid Kemiche, Isabelle Cerf-Payrastre & Edouard Pertuiset. (2015) R?mission compl?te sous azathioprine dans un cas de syndrome de Cogan corticor?sistant. La Presse M?dicale 44:10, pages 1066-1068.
Crossref
Gabriela M. Espinoza & Angela Prost. (2015) Cogan’s Syndrome and Other Ocular Vasculitides. Current Rheumatology Reports 17:4.
Crossref
Debora Jančatová, Karol Zeleník, Pavel Komínek & Petr Matoušek. (2015) Atypical Cogan's syndrome: A case report and summary of current treatment options. International Journal of Pediatric Otorhinolaryngology 79:3, pages 428-431.
Crossref
Ora Singer. (2015) Cogan and Behcet Syndromes. Rheumatic Disease Clinics of North America 41:1, pages 75-91.
Crossref
Edward Keystone & Mohammed A. Omair. 2015. Rheumatology. Rheumatology 485 491 .
Marina Mesquida, Blanca Molins, Victor Llorenç, Maite Sainz de la Maza & Alfredo Adán. (2014) Long-Term Effects of Tocilizumab Therapy for Refractory Uveitis-Related Macular Edema. Ophthalmology 121:12, pages 2380-2386.
Crossref
M Mesquida, A Leszczynska, V Llorenç & A Adán. (2014) Interleukin-6 blockade in ocular inflammatory diseases. Clinical and Experimental Immunology 176:3, pages 301-309.
Crossref
Aharon Kessel, Zahava Vadasz & Elias Toubi. (2014) Cogan syndrome — Pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews 13:4-5, pages 351-354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.